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Background
Mesenteric vein thrombosis (MVT) is a rare, often
lethal, entity that accounts for approximately 10-15% of
all cases of mesenteric ischemia [1,2]. Current indica-
tions for surgery in patients with acute MVT include
signs of peritonitis, bowel infarction and hemodynamic
instability.
In all other cases, long-lasting anticoagulation is the
strategy of choice [3,4], patients with MVT have a fairly
good prognosis and long-term outcomes once appropri-
ate anticoagulation is achieved [4,5]. At variance with
the slow onset of recanalization that takes place during
anticoagulation, thrombolysis leads to a rapid re-open-
ing of a vessel, with immediate tissue reperfusion [4].
Materials and methods
We have followed up each for at least 3 years. 32 MVT
patients (Table 1), 18 of whom (treated group) had
undergone percutaneous transhepatic thrombolysis and
mechanical thrombectomy prior to starting long-lasting
warfarin treatment. The other 14 patients (control
group) received only warfarin treatment. In each case
and for each patient, the rate of surgical approach
(bowel resection) and the rate of long-term mesenteric-
portal hypertension was evaluated.
Results
In 16/18 patients (88.8%) following the percutaneous
treatment, flow restoration in the thrombosed mesen-
teric vein was documented by direct portal venography
(Fig. 1). All patients with successfully recanalized MVT
did not develop recurrent episodes during the long-last-
ing (1 year) oral anticoagulation therapy. The 30-day
mortality rate was similar in the two groups (p=0.998).
Bowel resection was needed in 1 patient (5.5%) in the
treated group and in 5 patients (35.7%) in the control
group (p=0.022 as to the rate of short-term surgical
sequelae). A significant difference was also found as to
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Table 1 Clinical diagnosis on admission
Control Group Treated group Statistical significance
Asa
Asa 2
Asa 3
4
10
7
11
P = 0.712
Thrombosis localization
Mesenteric
Mesenterico-portal
Spleno-mesenter-portal
5
7
2
7
8
3
P = 0.950
Duration of symptom
≤ 2 day
≤ 7 day
≤ 14 day
1
9
4
2
10
6
P = 0.865
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any medium, provided the original work is properly cited.long-term sequelae, especially portal hypertension (7/14
patients in the control group, 50.0%; 2/18 patients in
the treated group, 11.1%; p=0.043) (Fig. 2).
Conclusions
MVT is still a serious disease, with a high mortality
rate (25-35%), mostly related to transmural necrosis
and bowel perforation due to the delay in diagnosis
[1,6]. In the absence of major clinical signs and symp-
toms, the severity of bowel ischemia on admission is
based on the evaluation of bowel wall thickness by
contrast-enhanced CT scan (90% sensitivity). Macro-
scopically infarcted small bowel without transmural
necrosis is potentially reversible with long-lasting
anticoagulation [1,7-10]. Encouraging results of endo-
vascular thrombolytic treatments have been reported
in literature [11,12]. According to our results, when
administered promptly, endovascular intervention
using percutaneous transhepatic thrombolysis and
mechanical thrombectomy appears to have a lower
rate of early and late complications compared to war-
farin treatment alone.
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